Histamine: A new immunomodulatory player in the neuron-glia crosstalk

Frontiers in Cellular Neuroscience

Volumn 8, Issue 1 APR, 2014, Pages

  Rocha, Sandra M ^a   Pires, Joel ^a   Esteves, Marta ^a   Baltazar, Graça ^a   Bernardino, Liliana ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

Author keywords

Histamine; Microglia; Neuroinflammation; Nitric oxide; Parkinson's disease; Substantia nigra

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CYTOCHROME C OXIDASE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE METHYLTRANSFERASE; HISTAMINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDOPAMINE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; VERY LATE ACTIVATION ANTIGEN 5;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; CELL SURVIVAL; DOPAMINERGIC TRANSMISSION; DOWN REGULATION; EXCITOTOXICITY; FLUORESCENCE ANALYSIS; HISTAMINE METABOLISM; HISTAMINE RELEASE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MICROGLIA; MRNA EXPRESSION ASSAY; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84899699754     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00120     Document Type: Article

References (55)

1. Agasse, F., Bernardino, L., Kristiansen, H., Christiansen, S. H., Ferreira, R., Silva, B., et al. (2008). Neuropeptide Y promotes neurogenesis in murine subventricular zone. Stem Cells 26, 1636-1645. doi: 10.1634/stemcells.2008-0056
2. Alonso, A., Jick, S. S., and Hernan, M. A. (2006). Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 66, 572-575. doi: 10.1212/01.wnl.0000198507.13597.45
3. Anichtchik, O. V., Rinne, J. O., Kalimo, H., and Panula, P. (2000a). An altered histaminergic innervation of the substantia nigra in Parkinson's disease. Exp. Neurol. 163, 20-30. doi: 10.1006/exnr.2000.7362
4. Azuma, Y., Shinohara, M., Wang, P. L., Hidaka, A., and Ohura, K. (2001). Histamine inhibits chemotaxis, phagocytosis, superoxide anion production, and the production of TNFalpha and IL-12 by macrophages via H2-receptors. Int. Immunopharmacol. 1, 1867-1875. doi: 10.1016/s1567-5769(01)00112-6
5. Bernardino, L., Agasse, F., Silva, B., Ferreira, R., Grade, S., and Malva, J. O. (2008). Tumor necrosis factor-alpha modulates survival, proliferation and neuronal differentiation in neonatal subventricular zone cell cultures. Stem Cells 26, 2361-2371. doi: 10.1634/stemcells.2007-0914
6. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69. doi: 10.1038/nrn2038
7. Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., and Cowart, M. D. (2011). Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer's disease. J. Pharmacol. Exp. Ther. 336, 38-46. doi: 10.1124/jpet.110.166876
8. Brown, G. C., and Neher, J. J. (2010). Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 41, 242-247. doi: 10.1007/s12035-010-8105-9
9. Campos, F. L., Cristovao, A. C., Rocha, S. M., Fonseca, C. P., and Baltazar, G. (2012). GDNF contributes to oestrogen-mediated protection of midbrain dopaminergic neurones. J. Neuroendocrinol. 24, 1386-1397. doi: 10.1111/j.1365-2826.2012.02348.x
10. Choi, D. Y., Liu, M., Hunter, R. L., Cass, W. A., Pandya, J. D., Sullivan, P. G., et al. (2009). Striatal neuroinflammation promotes Parkinsonism in rats. PLoS One 4:e5482. doi: 10.1371/journal.pone.0005482
11. Collins, L. M., Toulouse, A., Connor, T. J., and Nolan, Y. M. (2012). Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Neuropharmacology 62, 2154-2168. doi: 10.1016/j.neuropharm.2012.01.028
12. Croyal, M., Dauvilliers, Y., Labeeuw, O., Capet, M., Schwartz, J. C., and Robert, P. (2011). Histamine and tele-methylhistamine quantification in cerebrospinal fluid from narcoleptic subjects by liquid chromatography tandem mass spectrometry with precolumn derivatization. Anal. Biochem. 409, 28-36. doi: 10.1016/j.ab.2010.09.045
13. Fernandez-Novoa, L., and Cacabelos, R. (2001). Histamine function in brain disorders. Behav. Brain Res. 124, 213-233. doi: 10.1016/s0166-4328(01)00215-7
14. Ferreira, R., Santos, T., Goncalves, J., Baltazar, G., Ferreira, L., Agasse, F., et al. (2012). Histamine modulates microglia function. J. Neuroinflammation 9:90. doi: 10.1186/1742-2094-9-90
15. Ferstl, R., Akdis, C. A., and O'mahony, L. (2012). Histamine regulation of innate and adaptive immunity. Front. Biosci. (Landmark Ed.) 17, 40-53. doi: 10.2741/3914
16. Grade, S., Agasse, F., Bernardino, L., Silva, C. G., Cortes, L., and Malva, J. O. (2010). Functional identification of neural stem cell-derived oligodendrocytes by means of calcium transients elicited by thrombin. Rejuvenation Res.13, 27-37. doi: 10.1089/rej.2009.0889
17. Gschwandtner, M., Bunk, H., Kother, B., Thurmond, R. L., Kietzmann, M., Werfel, T., et al. (2012). Histamine down-regulates IL-27 production in antigen-presenting cells. J. Leukoc. Biol. 92, 21-29. doi: 10.1189/jlb.0111017
18. Haas, H. L., Sergeeva, O. A., and Selbach, O. (2008). Histamine in the nervous system. Physiol. Rev. 88, 1183-1241. doi: 10.1152/physrev.00043.2007
19. Hafner-Bratkovič, I., Benčina, M., Fitzgerald, K. A., Golenbock, D., and Jerala, R. (2012). NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity. Cell. Mol. Life Sci. 69, 4215-4228. doi: 10.1007/s00018-012-1140-0
20. Hernández-Angeles, A., Soria-Jasso, L. E., Ortega, A., and Arias-Montano, J. A. (2001). Histamine H1 receptor activation stimulates mitogenesis in human astrocytoma U373 MG cells. J. Neurooncol. 55, 81-89. doi: 10.1023/A:1013338515229
21. Jung, H. W., Son, H. Y., Minh, C. V., Kim, Y. H., and Park, Y. K. (2008). Methanol extract of Ficus leaf inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated microglia via the MAPK pathway. Phytother. Res. 22, 1064-1069. doi: 10.1002/ptr.2442
22. Jutel, M., Blaser, K., and Akdis, C. A. (2006). The role of histamine in regulation of immune responses. Chem. Immunol. Allergy 91, 174-187. doi: 10.1159/000090280
23. Jutel, M., Watanabe, T., Klunker, S., Akdis, M., Thomet, O. A., Malolepszy, J., et al. (2001). Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420-425. doi: 10.1038/35096564
24. Katoh, Y., Niimi, M., Yamamoto, Y., Kawamura, T., Morimoto-Ishizuka, T., Sawada, M., et al. (2001). Histamine production by cultured microglial cells of the mouse. Neurosci. Lett. 305, 181-184. doi: 10.1016/s0304-3940(01)01835-3
25. Kimura, S., Wang, K. Y., Tanimoto, A., Murata, Y., Nakashima, Y., and Sasaguri, Y. (2004). Acute inflammatory reactions caused by histamine via monocytes/macrophages chronically participate in the initiation and progression of atherosclerosis. Pathol. Int. 54, 465-474. doi: 10.1111/j.1440-1827.2004.01653.x
26. Knott, A. B., and Bossy-Wetzel, E. (2009). Nitric oxide in health and disease of the nervous system. Antioxid. Redox Signal. 11, 541-554. doi: 10.1089/ARS.2008.2234
27. Leurs, R., Chazot, P. L., Shenton, F. C., Lim, H. D., and De Esch, I. J. (2009). Molecular and biochemical pharmacology of the histamine H4 receptor. Br. J. Pharmacol. 157, 14-23. doi: 10.1111/j.1476-5381.2009.00250.x
28. Liu, C. Q., Chen, Z., Liu, F. X., Hu, D. N., and Luo, J. H. (2007). Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Neuropharmacology 53, 832-841. doi: 10.1016/j.neuropharm.2007.08.014
29. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., et al. (2002). Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508. doi: 10.1038/nm0502-500
30. Logothetis, L., Mylonas, I. A., Baloyannis, S., Pashalidou, M., Orologas, A., Zafeiropoulos, A., et al. (2005). A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Int. J. Immunopathol. Pharmacol. 18, 771-778.
31. Long-Smith, C. M., Sullivan, A. M., and Nolan, Y. M. (2009). The influence of microglia on the pathogenesis of Parkinson's disease. Prog. Neurobiol. 89, 277-287. doi: 10.1016/j.pneurobio.2009.08.001
32. Marone, G., Gentile, M., Petraroli, A., De Rosa, N., and Triggiani, M. (2001). Histamine-induced activation of human lung macrophages. Int. Arch. Allergy Immunol. 124, 249-252. doi: 10.1159/000053725
33. Molina-Hernández, A., Díaz, N. F., and Arias-Montaño, J. A. (2012). Histamine in brain development. J. Neurochem. 122, 872-882. doi: 10.1111/j.1471-4159.2012.07863.x
34. Molina-Hernández, A., and Velasco, I. (2008). Histamine induces neural stem cell proliferation and neuronal differentiation by activation of distinct histamine receptors. J. Neurochem. 106, 706-717. doi: 10.1111/j.1471-4159.2008.05424.x
35. Nathan, P. J., Boardley, R., Scott, N., Berges, A., Maruff, P., Sivananthan, T., et al. (2013). The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H(3) receptor antagonist in patients with mild to moderate Alzheimer's disease: a preliminary investigation. Curr. Alzheimer Res. 10, 240-251. doi: 10.2174/1567205011310030003
36. Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Buzas, E., et al. (2012). Characterization and function of histamine receptors in human bone marrow stromal cells. Stem Cells 30, 222-231. doi: 10.1002/stem.771
37. Nicolson, T. A., Bevan, S., and Richards, C. D. (2002). Characterisation of the calcium responses to histamine in capsaicin-sensitive and capsaicin-insensitive sensory neurones. Neuroscience 110, 329-338. doi: 10.1016/s0306-4522(01)00561-9
38. Nuutinen, S., and Panula, P. (2011). Histamine in neurotransmission and brain diseases. Adv. Exp. Med. Biol. 709, 95-107. doi: 10.1007/978-1-4419-8056-4_10
39. Palada, V., Terzic, J., Mazzulli, J., Bwala, G., Hagenah, J., Peterlin, B., et al. (2012). Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson's disease. Neurobiol. Aging 33, 836. e1-836. e3. doi: 10.1016/j.neurobiolaging.2011.06.015
40. Parmentier, R., Anaclet, C., Guhennec, C., Brousseau, E., Bricout, D., Giboulot, T., et al. (2007). The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. Biochem. Pharmacol. 73, 1157-1171. doi: 10.1016/j.bcp.2007.01.002
41. Passani, M. B., and Ballerini, C. (2012). Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis. Front. Syst. Neurosci. 6:32. doi: 10.3389/fnsys.2012.00032
42. Phani, S., Loike, J. D., and Przedborski, S. (2012). Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat. Disord. 18(Suppl. 1), S207-S209. doi: 10.1016/S1353-8020(11)70064-5
43. Polazzi, E., and Monti, B. (2010). Microglia and neuroprotection: from in vitro studies to therapeutic applications. Prog. Neurobiol. 92, 293-315. doi: 10.1016/j.pneurobio.2010.06.009
44. Rosa, A. I., Goncalves, J., Cortes, L., Bernardino, L., Malva, J. O., and Agasse, F. (2010). The angiogenic factor angiopoietin-1 is a proneurogenic peptide on subventricular zone stem/progenitor cells. J. Neurosci. 30, 4573-4584. doi: 10.1523/jneurosci.5597-09.2010
45. Rozniecki, J. J., Hauser, S. L., Stein, M., Lincoln, R., and Theoharides, T. C. (1995). Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37, 63-66. doi: 10.1002/ana.410370112
46. Saura, J., Tusell, J. M., and Serratosa, J. (2003). High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189. doi: 10.1002/glia.10274
47. Shan, L., Bossers, K., Luchetti, S., Balesar, R., Lethbridge, N., Chazot, P. L., et al. (2012). Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study. Neurobiol. Aging 33, 1488. e1-1488. e13. doi: 10.1016/j.neurobiolaging.2011.10.016
48. Shan, L., Swaab, D. F., and Bao, A. M. (2013). Neuronal histaminergic system in aging and age-related neurodegenerative disorders. Exp. Gerontol. 48, 603-607. doi: 10.1016/j.exger.2012.08.002
49. Strakhova, M. I., Nikkel, A. L., Manelli, A. M., Hsieh, G. C., Esbenshade, T. A., Brioni, J. D., et al. (2009). Localization of histamine H4 receptors in the central nervous system of human and rat. Brain Res. 1250, 41-48. doi: 10.1016/j.brainres.2008.11.018
50. Tanimoto, A., Wang, K. Y., Murata, Y., Kimura, S., Nomaguchi, M., Nakata, S., et al. (2007). Histamine upregulates the expression of inducible nitric oxide synthase in human intimal smooth muscle cells via histamine H1 receptor and NF-kappaB signaling pathway. Arterioscler. Thromb. Vasc. Biol. 27, 1556-1561. doi: 10.1161/atvbaha.106.139089
51. Tran, P. B., Ren, D., Veldhouse, T. J., and Miller, R. J. (2004). Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J. Neurosci. Res. 76, 20-34. doi: 10.1002/jnr.20001
52. Tuomisto, L., Kilpelainen, H., and Riekkinen, P. (1983). Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions 13, 255-257. doi: 10.1007/bf01967346
53. Vizuete, M. L., Merino, M., Venero, J. L., Santiago, M., Cano, J., and Machado, A. (2000). Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra. J. Neurochem. 75, 540-552. doi: 10.1046/j.1471-4159.2000.0750540.x
54. Vohora, D., and Bhowmik, M. (2012). Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia and drug abuse. Front. Syst. Neurosci. 6:72. doi: 10.3389/fnsys.2012.00072
55. Wang, L. D., Hoeltzel, M., Butler, K., Hare, B., Todisco, A., Wang, M., et al. (1997). Activation of the human histamine H2 receptor is linked to cell proliferation and c-fos gene transcription. Am. J. Physiol. 273, C2037-C2045.